From Prototype to Production: How to Scale Your Medical Device the Right Way

The materials you choose in early design sessions can influence process compatibility, regulatory requirements, supplier availability, and unit cost at scale. A material that works well for a prototype because it's available off the shelf, easy to work with in small quantities, and sufficient for bench testing may not be the right choice for production and can become sources of delays, increased costs, and regulatory setbacks.

Tolerance decisions made during prototyping often reflect what works on the bench, not what a production process can hold consistently across hundreds or thousands of units. Without a manufacturing review, those specifications can limit supplier options and process viability while increasing inspection costs.

ISO 13485 requires organizations to establish criteria for the evaluation, selection, monitoring, and re-evaluation of suppliers based on their ability to meet specified requirements.

What many teams discover too late is that this process has a timeline of its own. When supplier relationships are managed informally during development, qualification has to happen retroactively, often under pressure, and sometimes with the finding that the supplier can't meet the requirements at all.

A QMS is not a set of documents, it's the operating system your manufacturing process runs on. Design controls, change management, document control, and risk management should be integrated into development from the beginning, rather than assembled in the months before a regulatory submission. When those elements are built in parallel with the device, your development activities generate the records needed to support the applicable regulatory requirements.